Relay Therapeutics RLAY
NASDAQ RLAY
$18.18 -0.16 (-0.87%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

Relay Therapeutics (RLAY) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Relay Therapeutics 3.97 Bn 3.47 Bn - 118.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.30 Mn
Mar 31, 2026 83.80 Mn
Dec 31, 2025 69.46 Mn
Sep 30, 2025 97.80 Mn
Jun 30, 2025 84.10 Mn
Mar 31, 2025 64.82 Mn
Dec 31, 2024 104.07 Mn
Sep 30, 2024 139.20 Mn
Jun 30, 2024 165.20 Mn
Mar 31, 2024 203.10 Mn
Dec 31, 2023 196.61 Mn
Sep 30, 2023 156.71 Mn
Jun 30, 2023 118.94 Mn
Mar 31, 2023 175.04 Mn
Dec 31, 2022 183.02 Mn
Sep 30, 2022 85.12 Mn
Jun 30, 2022 69.50 Mn
Mar 31, 2022 18.10 Mn
Dec 31, 2021 35.25 Mn
Sep 30, 2021 30.00 Mn
API Access

Relay Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RLAY&period=max&api_key=YOUR_API_KEY